Beijing Tongrentang Co., Ltd (SHA:600085)
27.40
+0.08 (0.29%)
Apr 29, 2026, 11:29 AM CST
Beijing Tongrentang Revenue
In the year 2025, Beijing Tongrentang had annual revenue of 17.26B CNY, down -7.21%. Beijing Tongrentang had revenue of 3.95B in the quarter ending December 31, 2025, a decrease of -17.36%.
Revenue
17.26B
Revenue Growth
-7.21%
P/S Ratio
2.17
Revenue / Employee
998.39K
Employees
17,284
Market Cap
37.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 17.26B | -1.34B | -7.21% |
| Dec 31, 2024 | 18.60B | 736.39M | 4.12% |
| Dec 31, 2023 | 17.86B | 2.49B | 16.19% |
| Dec 31, 2022 | 15.37B | 769.32M | 5.27% |
| Dec 31, 2021 | 14.60B | 1.78B | 13.86% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dong-E-E-Jiao | 6.80B |
| Changchun High-Tech Industry (Group) | 11.67B |
| China Resources Sanjiu Medical & Pharmaceutical | 32.88B |
| Humanwell Healthcare (Group) | 23.96B |
| Shijiazhuang Yiling Pharmaceutical | 6.01B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 4.92B |
| Livzon Pharmaceutical Group | 11.71B |
| Dizal (Jiangsu) Pharmaceutical | 801.14M |